BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pryor JB, Weber BR, Weber JV, Lockridge JB, Olyaei AJ. Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review. Drugs Ther Perspect 2019;35:431-41. [DOI: 10.1007/s40267-019-00646-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Elnagar GM, Elseweidy MM, Elkomy NM, Keshawy MM, Fathy OM, Sobh MS, Mahmoud YK. Policosanol ameliorates renal inflammation and pyroptosis in hypercholesterolemic rabbits via modulation of HMGB1/PI3K/mTOR/NLRP3/Caspase-1 pathway. Journal of Functional Foods 2022;97:105250. [DOI: 10.1016/j.jff.2022.105250] [Reference Citation Analysis]
2 Shi X, Qu T, Van Pottelbergh G, van den Akker M, De Moor B. A Resampling Method to Improve the Prognostic Model of End-Stage Kidney Disease: A Better Strategy for Imbalanced Data. Front Med 2022;9:730748. [DOI: 10.3389/fmed.2022.730748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bagriy AВ, Khomenko MV, Shverova OI, Titievskaya ER. Therapy approaches in diabetic nephropathy (review of literature). Nefrologiâ (St -Peterbg ) 2021;25:18-30. [DOI: 10.36485/1561-6274-2021-25-1-18-30] [Reference Citation Analysis]